A government report on the effect of 1990s legislation to overcome gender disparities in clinical research reveals mixed results. Here’s how Cleveland Clinic is working to overcome the differences.
Learn about featured Cancer clinical trials currently enrolling, or search our Cancer clinical trials database for all open and accruing studies
Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas provides treatment options for Alzheimer’s disease patients and support for their caregivers.
Interim results from a major study of a leadless pacemaker show good safety and efficacy, echoing a recent trial of a similar device. Here’s how these devices may shape the future of cardiac pacing.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A novel metabolite of an approved agent for metastatic prostate cancer, Δ4-abiraterone, may be more effective than the parent drug, abiraterone, Cleveland Clinic researchers have found. They now will examine how D4A may prolong survival.
Two agents in the new PCSK9 inhibitor class just won recommendations for approval from an FDA advisory panel. Here’s why one expert sees them as a breakthrough in how high cholesterol is treated.
The Lou Ruvo Center for Brain Health is working to transform the clinical trial process for Alzheimer disease. It is committed to focusing on the right patients, the right drugs and the right outcomes.
The ACA Sunshine Act may have more potential to adversely affect physician participation in research than to harm physicians’ reputations.
Learn about featured cancer clinical trials currently enrolling
Developing treatments for T-cell lymphoma has been challenging due to the limited number of study participants and an inability to identify the molecular pathways leading to the disease. Cleveland Clinic investigators are involved in several projects intended to increase treatment options.